[Management of osteoporosis by using biochemical markers for bone turnover].
Mizunuma
Hideki
H
Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine.
D000469:Alkaline Phosphatase / Q000032:analysis; D000596:Amino Acids / Q000032:analysis; D015415:Biomarkers / Q000032:analysis; D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D016723:Bone Remodeling; D001862:Bone Resorption / Q000175:diagnosis; D001842:Bone and Bones / Q000378:metabolism*; D024042:Collagen Type I / Q000032:analysis; D006801:Humans; D010012:Osteogenesis; D010024:Osteoporosis / Q000175:diagnosis* / Q000188:drug therapy* / Q000378:metabolism; D010446:Peptide Fragments / Q000032:analysis; D010455:Peptides / Q000032:analysis; D011347:Procollagen / Q000032:analysis
D000596:Amino Acids; D015415:Biomarkers; D050071:Bone Density Conservation Agents; D024042:Collagen Type I; D010446:Peptide Fragments; D010455:Peptides; D011347:Procollagen; C052929:collagen type I trimeric cross-linked peptide; C047202:procollagen Type I N-terminal peptide; C036020:deoxypyridinoline; D000469:Alkaline Phosphatase